Anticancer Monoclonal Antibodies
Targeted therapy and naming the antibodies: anti-EGFR agents, trastuzumab for HER2, and bevacizumab and aflibercept.
This one is for members. Sign in — or make an account, it is free — and it will open.
Sign in to read it